Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Inhal Toxicol ; 22(1): 56-68, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19538086

ABSTRACT

Since fibrous particles such as asbestos and some man-made fibers (MMF) have been known to produce carcinogenic or fibrogenic effects, disk-shaped potassium octatitanate (POT) particles (trade name: Terracess TF) were manufactured as nonfibrous particles. A 90-day inhalation toxicity study of Terracess TF was performed to evaluate comparative inhalation toxicity of the disk shape with a fibrous shape that was previously evaluated. Four groups of 20 male and 15 female rats each were exposed to Terracess TF aerosols at concentrations of 0, 2, 10, or 50 mg/m(3) for 90 days. Ten male and 10 female rats per group were sacrificed at 90 days of exposure. After 90 days of exposure, 5 male rats per group were sacrificed at 3 wk of recovery period and 4-5 male rats per group or 5 female rats per group were sacrificed at 15 wk of recovery for lung clearance and histopathology. The mass median aerodynamic equivalent diameter (MMAED) of the aerosols of test materials ranged from 2.5 to 2.9 microm. There were no test-substance-related adverse effects on clinical observations. At the end of the 90-day exposure, a slight increase in lung-to-body weight ratios was observed at 50 mg/m(3) in male but not in female rats. However, lung weights were within normal limits after 3- or 15-wk recovery periods. Microscopically, inhaled Terracess TF particles were mostly phagocytized by free alveolar macrophages (AMs) in the alveolar airspaces and alveolar walls maintained normal structure at 2 and 10 mg/m(3). At 50 mg/m(3), some alveoli were distended and filled with aggregates of particle-laden AMs. The alveolar walls showed slight type II pneumocyte hyperplasia, but neither proliferative inflammation nor alveolar fibrosis was present at 50 mg/m(3). The clearance half-times for Terracess TF were estimated to be in the order of 6 to 9 mo for the 50-mg/m(3) group and 2 to 3 mo for the 10- and 2-mg/m(3) groups. The lung responses and lung clearance rate were comparable to those of "nuisance" type dusts at these concentrations. Based on interpretation that aggregated particle-laden AMs in alveoli was considered to be an early histopathological sign of lung overloading, an effect level was considered to be 50 mg/m(3) and no-observedadverse- effect level (NOAEL) was 10 mg/m(3). This experiment clearly demonstrated that particle morphology was considered to be an important factor to determine inhaled particle toxicity.


Subject(s)
Lung/drug effects , Minerals/toxicity , Titanium/toxicity , Aerosols , Animals , Female , Inhalation Exposure , Lung/pathology , Macrophages, Alveolar/drug effects , Macrophages, Alveolar/physiology , Male , Metabolic Clearance Rate , Minerals/pharmacokinetics , Organ Size , Particle Size , Phagocytosis/drug effects , Phagocytosis/physiology , Rats , Recovery of Function , Titanium/pharmacokinetics
3.
Cancer Res ; 64(3): 1067-70, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14871839

ABSTRACT

New analogues of the minor groove binding ligand Hoechst 33342 have been investigated in an attempt to improve radioprotective activity. The synthesis, DNA binding, and in vitro radioprotective properties of methylproamine, the most potent derivative, are reported. Experiments with V79 cells have shown that methylproamine is approximately 100-fold more potent than the classical aminothiol radioprotector WR1065. The crystal structures of methylproamine and proamine complexes with the dodecamer d(CGCGAATTCGCG)(2) confirm that the new analogues also are minor groove binders. It is proposed that the DNA-bound methylproamine ligand acts as a reducing agent by an electron transfer mechanism, repairing transient radiation-induced oxidizing species on DNA.


Subject(s)
Benzimidazoles/pharmacology , Radiation-Protective Agents/pharmacology , Animals , Benzimidazoles/chemistry , Benzimidazoles/metabolism , Cells, Cultured , Cricetinae , Crystallography, X-Ray , DNA/metabolism , Fibroblasts/drug effects , Fibroblasts/radiation effects , Kinetics , Ligands , Models, Molecular , Nucleic Acid Conformation , Radiation-Protective Agents/chemistry , Radiation-Protective Agents/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...